JENBURKT PHARMACEUTICALS
Back to Balance Sheet
|
JENBURKT PHARMACEUTICALS Last 5 Year Total Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹195 Cr | ₹164 Cr | ₹141 Cr | ₹143 Cr | ₹120 Cr |
What is the latest Total Liabilities ratio of JENBURKT PHARMACEUTICALS ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹195 Cr |
| Mar2024 | ₹164 Cr |
| Mar2023 | ₹141 Cr |
| Mar2022 | ₹143 Cr |
| Mar2021 | ₹120 Cr |
How is Total Liabilities of JENBURKT PHARMACEUTICALS Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹195 Cr | 18.51 | |
| Mar2024 | ₹164 Cr | 16.21 | |
| Mar2023 | ₹141 Cr | -0.84 | |
| Mar2022 | ₹143 Cr | 18.38 | |
| Mar2021 | ₹120 Cr | - | |
Compare Total Liabilities of peers of JENBURKT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| JENBURKT PHARMACEUTICALS | ₹451.2 Cr | -6.9% | -5.6% | -14.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹391,488.0 Cr | -2.5% | -7% | -8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,415.0 Cr | -2.2% | -7.2% | 1.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹132,906.0 Cr | -4% | 2.8% | 27.1% | Stock Analytics | |
| CIPLA | ₹106,210.0 Cr | -5.5% | -12.4% | -5.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,089.0 Cr | 5.9% | -3.7% | -6.5% | Stock Analytics | |
JENBURKT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| JENBURKT PHARMACEUTICALS | -6.9% |
-5.6% |
-14.8% |
| SENSEX | -2.4% |
-4.7% |
6.4% |
You may also like the below Video Courses